Stroke
Feature
Renowned stroke expert Ralph L. Sacco, MD, dies
Dr. Sacco, the only physician to have served as president of both the American Heart Association and American Academy of Neurology, was 65.
From the Journals
Is thrombolysis safe for stroke patients on DOACs?
“Our results suggest that current guidelines need to be revised to remove the absolute contraindication of thrombolysis in patients on DOACs.”
From the Journals
Statins tied to lower ICH risk regardless of bleed location
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance...
30th Anniversary
Stroke management: A 30-year retrospective
Dr. Louis Caplan looks back on the successes and failures in stroke research and treatment.
Literature Review
High drug costs exclude most neurology patients from cutting-edge treatment
“Our study of people with neurologic conditions found that fewer than 20% were being treated with new medications.”
Conference Coverage
Single chest x-ray could predict 10-year CVD risk
Researchers trained a deep-learning model with single chest x-rays only.
Literature Review
Advancing health equity in neurology is essential to patient care
The final plenary session at the ANA annual conference offered insights into the underlying causes of health care disparities within neurology and...
Latest News
Mortality after acute stroke worsened by accompanying acute AFib
A comprehensive understanding of the relationship between acute AF and risk for acute ischemic stroke and prognosis will help improve management...
Feature
Medical school culinary medicine programs grow despite limited funding
As part of Dr. Marvasti’s program, students learn cooking fundamentals through chef demonstrations and hands-on practice – to teach students how...
From the Journals
Flu vaccination associated with reduced stroke risk
“What we were most surprised by was the sheer magnitude of the effect and that it existed across different adult age groups, for both sexes, and...
Conference Coverage
No benefit of rivaroxaban in COVID outpatients: PREVENT-HD
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.